DK482181A - Tumorlokalisering og terapi med maerkede antistoffer og antiser toffragmenter der er specifikke for tumorassocierede markfoer - Google Patents

Tumorlokalisering og terapi med maerkede antistoffer og antiser toffragmenter der er specifikke for tumorassocierede markfoer

Info

Publication number
DK482181A
DK482181A DK482181A DK482181A DK482181A DK 482181 A DK482181 A DK 482181A DK 482181 A DK482181 A DK 482181A DK 482181 A DK482181 A DK 482181A DK 482181 A DK482181 A DK 482181A
Authority
DK
Denmark
Prior art keywords
tumor
antises
tographs
therapy
specific
Prior art date
Application number
DK482181A
Other languages
Danish (da)
English (en)
Inventor
M D Goldenberg
Original Assignee
M D Goldenberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27383377&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK482181(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/126,263 external-priority patent/US4331647A/en
Priority claimed from US06/126,262 external-priority patent/US4348376A/en
Priority claimed from US06/126,261 external-priority patent/US4361544A/en
Application filed by M D Goldenberg filed Critical M D Goldenberg
Publication of DK482181A publication Critical patent/DK482181A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Testing Of Coins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Radiation-Therapy Devices (AREA)
  • Nuclear Medicine (AREA)
DK482181A 1980-03-03 1981-11-02 Tumorlokalisering og terapi med maerkede antistoffer og antiser toffragmenter der er specifikke for tumorassocierede markfoer DK482181A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/126,263 US4331647A (en) 1980-03-03 1980-03-03 Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US06/126,262 US4348376A (en) 1980-03-03 1980-03-03 Tumor localization and therapy with labeled anti-CEA antibody
US06/126,261 US4361544A (en) 1980-03-03 1980-03-03 Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
PCT/US1981/000261 WO1981002522A1 (en) 1980-03-03 1981-03-02 Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers

Publications (1)

Publication Number Publication Date
DK482181A true DK482181A (da) 1981-11-02

Family

ID=27383377

Family Applications (1)

Application Number Title Priority Date Filing Date
DK482181A DK482181A (da) 1980-03-03 1981-11-02 Tumorlokalisering og terapi med maerkede antistoffer og antiser toffragmenter der er specifikke for tumorassocierede markfoer

Country Status (9)

Country Link
EP (1) EP0035265B1 (de)
JP (5) JPH036125B2 (de)
AU (2) AU556548B2 (de)
CA (1) CA1244344A (de)
DE (1) DE3173342D1 (de)
DK (1) DK482181A (de)
IE (1) IE52040B1 (de)
IL (1) IL62267A (de)
WO (1) WO1981002522A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3173342D1 (en) * 1980-03-03 1986-02-13 Milton David Goldenberg Agent for tumor localization and therapy with labeled antibodies and antibody fragments
NO169947C (no) * 1981-10-27 1992-08-26 Hybritech Inc Fremgangsmaate for fremstilling av et monoklonalt antistoff til et tumorassosiert antigen
DE3382317D1 (de) * 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
CA1194415A (en) * 1982-05-05 1985-10-01 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
EP0131627B1 (de) * 1983-01-21 1992-05-20 PRIMUS, Frederick James Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikörper und verfahren zu ihrer verwendung
AU577781B2 (en) * 1983-04-28 1988-10-06 Mark Philip Best Lung imaging with radiolabelled agents
CA1242643A (en) * 1983-08-12 1988-10-04 Eric T. Fossel Nmr imaging utilizing chemical shift reagents
JPS60201260A (ja) * 1984-03-27 1985-10-11 Yamasa Shoyu Co Ltd 心疾患診断薬
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US4824659A (en) * 1985-06-07 1989-04-25 Immunomedics, Inc. Antibody conjugates
US5776093A (en) 1985-07-05 1998-07-07 Immunomedics, Inc. Method for imaging and treating organs and tissues
US4735210A (en) * 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit
EP0221653A3 (de) * 1985-09-20 1989-02-15 The Regents Of The University Of California Verfahren zur doppelisotop-farbfunktionellen Erfassung mittels radiomarkierter monoklonaler Antikörper, Reagenzsätze dafür und Antikörper zur Verwendung in diesem Verfahren
GB8525974D0 (en) * 1985-10-22 1985-11-27 Nyegaard & Co As Chemical substance
FR2604092B1 (fr) * 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
US5164175A (en) * 1986-12-10 1992-11-17 Hoechst Aktiengesellschaft Diagnostic aid containing an organ-specific substance labeled with technetium-99m
US4867962A (en) * 1988-02-26 1989-09-19 Neorx Corporation Functionally specific antibodies
CA1339415C (en) * 1989-08-24 1997-09-02 Milton David Goldenberg Detection and treatment of infections with immunoconjugates
CA2086531A1 (en) * 1990-07-03 1992-01-04 Ebo S. Bos Immunoreactive compound
GB9115192D0 (en) * 1991-07-12 1991-08-28 Antisoma Ltd Cancer treatment
KR19980038203A (ko) * 1996-11-25 1998-08-05 규오 리 헤 항-간암 마우스 모노클로날 항체에 의해 전달되는 방사성소핵체를 함유하는 의약
BRPI0717395A2 (pt) * 2006-10-25 2013-10-15 Koninkl Philips Electronics Nv Composto para diagnosticar câncer de próstata em um indivíduo humano ou animal, composição farmacêutica, e, uso de um composto ou uma composição

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960827A (en) * 1972-07-10 1976-06-01 Bjoerklund K B Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent
US4211766A (en) * 1972-07-10 1980-07-08 Ab Bonnierforetagen Cancer associated polypeptide antigen compositions
US3927193A (en) * 1973-05-18 1975-12-16 Hoffmann La Roche Localization of tumors by radiolabelled antibodies
US4160018A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Stabilized cancer associated polypeptide antigen and preparation thereof
DE2643208C2 (de) * 1976-09-25 1985-09-05 Behringwerke Ag, 3550 Marburg Immunologisches Bestimmungsverfahren
US4160817A (en) * 1976-09-29 1979-07-10 Research Corporation Application of protein-protein interaction as an assay for the detection of cancer
US4174385A (en) * 1976-10-08 1979-11-13 Robert Reid Method of identification of surface proteins of cancer cells, clinical test and method of immunization
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
US4234561A (en) * 1978-02-06 1980-11-18 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
ZA792457B (en) * 1978-05-22 1981-05-27 Serono Lab Method and composition for cancer detection in humans
AU529951B2 (en) * 1979-10-22 1983-06-30 Samuel Bogoch Detection of malignant tumour cells
DE3173342D1 (en) * 1980-03-03 1986-02-13 Milton David Goldenberg Agent for tumor localization and therapy with labeled antibodies and antibody fragments

Also Published As

Publication number Publication date
JPH03141230A (ja) 1991-06-17
EP0035265A2 (de) 1981-09-09
EP0035265A3 (en) 1982-04-07
AU7034181A (en) 1981-09-23
CA1244344A (en) 1988-11-08
AU556548B2 (en) 1986-11-06
JPH0684315B2 (ja) 1994-10-26
WO1981002522A1 (en) 1981-09-17
IL62267A (en) 1985-05-31
EP0035265B1 (de) 1986-01-02
JPH03141231A (ja) 1991-06-17
JPH0684313B2 (ja) 1994-10-26
AU6786887A (en) 1987-04-30
JPH0720887B2 (ja) 1995-03-08
AU581555B2 (en) 1989-02-23
JPH036125B2 (de) 1991-01-29
DE3173342D1 (en) 1986-02-13
JPH03157337A (ja) 1991-07-05
IE52040B1 (en) 1987-05-27
JPH03157338A (ja) 1991-07-05
JPH0684314B2 (ja) 1994-10-26
IL62267A0 (en) 1981-05-20
JPS57500195A (de) 1982-02-04
IE810451L (en) 1981-09-03

Similar Documents

Publication Publication Date Title
DK482181A (da) Tumorlokalisering og terapi med maerkede antistoffer og antiser toffragmenter der er specifikke for tumorassocierede markfoer
KR880700061A (ko) 인체 암종양과 관련된 항원에 대한 단클론성 항체
ZA811384B (en) Labeled antibodies and antibody fragments specific to tumor-associated markers, compositions thereof and use thereof in tumor localization an therapy
AR225617A1 (es) Conjunto de piezas para la practica de cultura fisica y para fisioterapia
DK257183D0 (da) Isonitril-radionuclidkomplekser og deres anvendelse til maerknings-og afbildningsmidler
IT1171646B (it) Composti benzoeterociclici e procedimento per prepararli
JPS54143513A (en) Production of antibody for malignant tumor
FI814003L (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara inolderivat
IT1140050B (it) Produzione di anticorpi monoclonali umani mediante ibridomi umani
NO151100C (no) Fremgangsmaate og apparat for ekkolokalisering av gjenstander
BR8108757A (pt) Beneficiamento magnetico de argilas utilizando flotacao e semeadura magnetica
IT1009463B (it) Procedimento per il preriscalda mento e la fusione continua di mi nerali ferrosi preridotti
ZA796918B (en) Pharmaceutical composition for treating neoplastic diseases and methods of preparation
NO149811C (no) Fremgangsmaate for rensning av p-aminofenol
DE3367281D1 (en) Method of determining immune complexes specific to tumor associated antigen
IT1055978B (it) Fusione di enzima immobilizzato e procedimento per la sua preparazione
DK331581A (da) Saltlage og fremgangsmaade til anvendelse deraf
IT1121005B (it) Procedimento e composizione per il trattamento della dissenteria suina
FI831258A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara benzimidazolderivat
JPS5264166A (en) Method of treating cattle feces
IS1122B6 (is) Nýjar decahydroquinolinol efnablöndur, aðferð tilframleiðslu þeirra og notkunar til lækninga
DK343481A (da) Substitueret ureidobenzylpenicillansyre og fremgangsmaade til fremstilling deraf
NO850574L (no) Apparat for fremdrift av baand
FI803574L (fi) Foerfarande foer framstaellning av kokvaetska erforderlig i neutralsulfitkok med antrakinonoekning
KR830000416U (ko) 자기치료부재

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment